US 9266928
Deletion of the beta 20-21 loop in HIV GP120 exposes the CD4 binding site for improved antibody binding and antibody induction
granted A61KA61K2039/5258A61K2039/545
Quick answer
US patent 9266928 (Deletion of the beta 20-21 loop in HIV GP120 exposes the CD4 binding site for improved antibody binding and antibody induction) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/5258, A61K2039/545, A61K2039/55505, A61K2039/55561